Saab shares continue to go from strength to strength. Q117 results confirm the company is on track to achieve above targeted organic sales development in the near term. Order intake remains positive and prospects for the new and upgraded versions of the Gripen fighter aircraft remain strong, aided by the improving trends in defence spending. The shares are trading once again at record levels, and the rating requires a continuing conversion of the pipeline into firm activity.
Written by
Saab |
Prize fighter
|
Aerospace & Defence |
QuickView
27 April 2017 |
Share price graph
Share details
Business description
Bull
Bear
Analysts
|
||||||||||||||||||||||||||
Saab shares continue to go from strength to strength. Q117 results confirm the company is on track to achieve above targeted organic sales development in the near term. Order intake remains positive and prospects for the new and upgraded versions of the Gripen fighter aircraft remain strong, aided by the improving trends in defence spending. The shares are trading once again at record levels, and the rating requires a continuing conversion of the pipeline into firm activity.
Strong start to 2017
A positive book to bill ratio during Q117 drove the order book up to SEK109.4bn at the end of the quarter. The strong order intake during the period of SEK9.7bn was driven by two large orders; one for the second GlobalEye AEW (Airborne Early Warning) system, the other an anti-ship missile contract for the Dynamics activity. SEK20.1bn of the order backlog at Q117 is deliverable in the remainder of the year which gives a strong underpinning to FY17 sales estimates, with a further similar amount booked for delivery in FY18. Organic revenue growth of 8% was driven mainly by activity in the Gripen, A26 submarine and GlobalEye programmes. Despite continued high level of investment, notably in the T-X lead-in trainer aircraft programme for the US, operating margins rose to 6.6% from 4.3% in Q116. This was accompanied by an improvement in EBIT margin in all of the divisions except Kockums which experienced a slight decline. Cash flow was positive during the quarter with net debt falling to SEK0.87bn at Q117 (from SEK1.84bn at FY16).
Defence prospects increasingly positive
News that coincided with Q1 results came from Bulgaria, where the interim defence minister indicated that the country is to start negotiations to buy eight new Gripen aircraft. With many other campaigns also active, and when combined with improved prospect for defence spending globally, Saab remains well positioned to attain its medium-term 5% sales growth target, and should exceed this in the current year. Management guidance is for operating margins to improve compared to FY16, making progress towards its 10% goal.
Valuation: Premium rating achieved
The return to growth for Saab is now being confirmed, justifying the strong performance of the stock seen over the last few years. The delivery of the anticipated levels of profitability would still leave the rating extended, and we would not be surprised if Saab’s shares now faced a period of consolidation.
|
Consensus estimates
Source: Bloomberg |
EDISON QUICKVIEWS ARE NORMALLY ONE OFF PUBLICATIONS WITH NO COMMITMENT TO WRITING ANY FOLLOW UP. QUICKVIEW NOTES USE CONSENSUS EARNINGS ESTIMATES.
|
Disclaimer
|
|
Disclaimer
|
Middlefield Canadian Income (MCT) is listed on the Main Market of the London Stock Exchange. It aims to invest in a diversified portfolio of Canadian and selected US companies that are able to pay high sustainable or growing dividends and have the potential to generate long-term capital growth. On a sector basis, the trust currently has high exposure to the pipelines, power & utility and real estate sectors. MCT is benchmarked against the S&P/TSX Composite High Dividend Index, which it has outperformed over one, three and five years. MCT currently pays a regular quarterly dividend of 1.25p, although the board has recently proposed a modest increase to 1.275p; its current dividend yield is 4.7%.